Stock VKTX VIKING THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/05/2024 BST 		After market 22:33:21
64.23 USD -4.87% Intraday chart for Viking Therapeutics, Inc. 64.24 +0.02%
05-17 Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform MT
05-17 North American Morning Briefing : The "Everything -2- DJ

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform
MT
North American Morning Briefing : The "Everything -2-
DJ
Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing
MT
Wall St set to open sharply higher on soft jobs data
RE
Amgen shares jump after teasing weight-loss drug data, rivals slip
RE
Viking Therapeutics Insider Sold Shares Worth $22,136,474, According to a Recent SEC Filing
MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday
MT
Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours
MT
Transcript : Viking Therapeutics, Inc., Q1 2024 Earnings Call, Apr 24, 2024
Viking Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
6 Stocks Positioned to Soar as Investors Focus on MASH
AQ
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
PR
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup
DJ
Health Care Down on Flight From Risk -- Health Care Roundup
DJ
Health Care Down as Obesity-Drug Optimism Fades -- Health Care Roundup
DJ
Oppenheimer Adjusts Viking Therapeutics Price Target to $138 From $116, Maintains Outperform Rating
MT
Health Care Climbs on Weight-Loss Drug Excitement -- Health Care Roundup
DJ
Sector Update: Health Care Stocks Rise Tuesday Afternoon
MT
Sector Update: Health Care
MT
Stifel Adjusts Viking Therapeutics Price Target to $95 From $80, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VKTX Stock
  4. News Viking Therapeutics, Inc.